vidarabine has been researched along with Chromosomal Fragility in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arakawa, S; Hamanoue, S; Inoue, H; Ishiguro, H; Katob, S; Koike, T; Masukawa, A; Matsumoto, M; Miyachi, H; Morimoto, T; Ohshima, T; Yabe, H; Yabe, M; Yamashita, T | 1 |
| Leonard, JC; Leonard, RC; Thompson, KH | 1 |
2 other study(ies) available for vidarabine and Chromosomal Fragility
| Article | Year |
|---|---|
In vitro effect of fludarabine, cyclophosphamide, and cytosine arabinoside on chromosome breakage in Fanconi anemia patients: relevance to stem cell transplantation.
Topics: Antimetabolites, Antineoplastic; Cells, Cultured; Chromosome Breakage; Chromosome Fragility; Cyclophosphamide; Cytarabine; Fanconi Anemia; Female; Humans; Male; Myeloablative Agonists; Stem Cell Transplantation; Transplantation Conditioning; Vidarabine | 2007 |
Arabinofuranosyl nucleosides induce common fragile sites.
Topics: Aphidicolin; Chromosome Fragile Sites; Chromosome Fragility; Cytarabine; Diterpenes; Female; Humans; Male; Nucleic Acid Synthesis Inhibitors; Vidarabine | 1988 |